These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

50 related items for PubMed ID: 15056475

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype.
    Tadros MG, Khalifa AE, Abdel-Naim AB, Arafa HM.
    Pharmacol Biochem Behav; 2005 Nov; 82(3):574-82. PubMed ID: 16337998
    [Abstract] [Full Text] [Related]

  • 3. Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats.
    Pandey M, Borah A, Varghese M, Barman PK, Mohanakumar KP, Usha R.
    Neurochem Int; 2009 Nov; 55(6):431-7. PubMed ID: 19410615
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
    Kumar P, Kumar A.
    Eur J Pharmacol; 2009 Aug 01; 615(1-3):91-101. PubMed ID: 19445928
    [Abstract] [Full Text] [Related]

  • 9. Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats.
    Dhir A, Akula KK, Kulkarni SK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):835-43. PubMed ID: 18234412
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effect of three inhaled anesthetics in mice harboring mutations in the GluR6 (kainate) receptor gene.
    Sonner JM, Vissel B, Royle G, Maurer A, Gong D, Baron NV, Harrison N, Fanselow M, Eger EI.
    Anesth Analg; 2005 Jul 01; 101(1):143-8, table of contents. PubMed ID: 15976221
    [Abstract] [Full Text] [Related]

  • 16. Mitochondrial NAD+-linked State 3 respiration and complex-I activity are compromised in the cerebral cortex of 3-nitropropionic acid-induced rat model of Huntington's disease.
    Pandey M, Varghese M, Sindhu KM, Sreetama S, Navneet AK, Mohanakumar KP, Usha R.
    J Neurochem; 2008 Jan 01; 104(2):420-34. PubMed ID: 17953654
    [Abstract] [Full Text] [Related]

  • 17. Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6/2 Huntington's disease mice.
    Domenici MR, Scattoni ML, Martire A, Lastoria G, Potenza RL, Borioni A, Venerosi A, Calamandrei G, Popoli P.
    Neurobiol Dis; 2007 Nov 01; 28(2):197-205. PubMed ID: 17720507
    [Abstract] [Full Text] [Related]

  • 18. A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease.
    Keene CD, Rodrigues CM, Eich T, Linehan-Stieers C, Abt A, Kren BT, Steer CJ, Low WC.
    Exp Neurol; 2001 Oct 01; 171(2):351-60. PubMed ID: 11573988
    [Abstract] [Full Text] [Related]

  • 19. Glutamate toxicity in the striatum of the R6/2 Huntington's disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters.
    Estrada-Sánchez AM, Montiel T, Segovia J, Massieu L.
    Neurobiol Dis; 2009 Apr 01; 34(1):78-86. PubMed ID: 19168136
    [Abstract] [Full Text] [Related]

  • 20. Striatal transplantation in a transgenic mouse model of Huntington's disease.
    Dunnett SB, Carter RJ, Watts C, Torres EM, Mahal A, Mangiarini L, Bates G, Morton AJ.
    Exp Neurol; 1998 Nov 01; 154(1):31-40. PubMed ID: 9875265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.